2007 Annual Meeting | Update in Childhood Headache

Date Friday 05/04/07

Time 01:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN

Topic(s) Headache/Other Pain Syndromes

Learning Objectives Participants should be able to utilize standardized International Classifiction of Headache Disorders, Second Revision (ICHD-II) criteria to accurately diagnose childhood headache disorders; develop effective treatment approaches for patients based on the most up-to-date data while basing this decision on the underlying pathophysiology; develop an understanding of the significant impact of headaches on children's and parents' lives and how to easily measure this in their practice; attain insight in the treatment of difficult pediatric headaches, including status migrainous, intractable headache, and chronic daily headache.

CME Available No CME available

Core Competencies Interpersonal and Communication Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Resident, Nurse

Event Timeline
01:15 PM - 01:25 PM		Introduction: Cases in Pediatric Headache Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN
01:25 PM - 01:55 PM		Using Standardized Criteria to Diagnose, Evaluate, and Understand the Epidemiology of Pediatric Headache Paul Winner, DO, FAAN
01:55 PM - 02:25 PM		The Impact and Pathophysiology of Pediatric Headache Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN
02:25 PM - 02:40 PM		Break
02:40 PM - 03:10 PM		Acute Treatment: How Can We Stop the Headache? Steven L. Linder, MD
03:10 PM - 03:40 PM		Prevention: How Do We Treat Frequent Headaches and Chronic Migraine? Marcy E. Yonker, MD
03:40 PM - 04:20 PM		What Do We Do When Things Go Wrong: ED and Inpatient Treatment Marielle K. Samaha, MD, FAHS, FAAN, FAAN
04:20 PM - 04:45 PM		Discussion: What Can We Learn From Our Patients?
04:45 PM - 05:00 PM		Questions and Answers

Faculty Disclosures
Steven L. Linder, MD	No disclosure on file
Paul Winner, DO, FAAN	Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Marcy E. Yonker, MD	The institution of Dr. Yonker has received research support from NINDS. The institution of Dr. Yonker has received research support from PCORI. The institution of Dr. Yonker has received research support from TEVA. The institution of Dr. Yonker has received research support from AMGEN. The institution of Dr. Yonker has received research support from Pfizer. The institution of Dr. Yonker has received research support from Lilly. The institution of Dr. Yonker has received research support from Abbvie.
Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN	The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Marielle K. Samaha, MD, FAHS, FAAN, FAAN	Dr. Samaha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for theranica. Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAN . The institution of Dr. Samaha has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AAP.

��ɫ��

��ɫ��